Pharmaceutical Lek Ready for a Possible Hostile Takeover Attempt

Ljubljana, 24 June - Lek has been purchasing its own shares ever since it was privatised, and this stock of shares is also intended for defence from hostile takeovers, CEO of this pharmaceutical company Metod Dragonja said Monday as the company's AGM convened to distribute the SIT 20.93bn (EUR 92.5m) of balance sheet profits. SIT 2.23bn (EUR 9.86m) have been allocated for dividends, which total SIT 1200 (EUR 5.3) per share.